Paper41486563
A Natural Sweetener-inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals.
Qiao L and 16 others. Adv Sci (Weinh), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A Natural Sweetener-inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals. Papers, record 41486563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41486563
- Cell line
- HeLa892 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Natural Sweetener-inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals.
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sweetening Agents | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Diabetes Mellitus, Type 1 | |
| Disease Models, Animal | |
| Obesity |
Source PubMed
Grants13
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 32171414 | National Natural Science Foundation of China | PubMed | ||
| 32250010:32261160373:32430064 | National Natural Science Foundation of China | PubMed | ||
| BX20250121 | Postdoctoral Fellowship Program and China Postdoctoral Science Foundation | PubMed | ||
| 2025M772716 | Postdoctoral Fellowship Program and China Postdoctoral Science Foundation | PubMed | ||
| 23ZR1419500 | Natural Science Foundation of Shanghai | PubMed | ||
| CSTB2022NSCQ-MSX0461 | Natural Science Foundation of Chongqing | PubMed | ||
| 32401213 | Young Scientists Fund of the National Natural Science Foundation of China | PubMed | ||
| 3250120102 | Young Scientists Fund of the National Natural Science Foundation of China | PubMed | ||
| 2023ZD0501300 | Noncommunicable Chronic Diseases-National Science and Technology Major Project | PubMed | ||
| 23HC1410100:25HC2830300 | Science and Technology Commission of Shanghai Municipality | PubMed | ||
| ZDTS24-RX | Sixth Cycle Key Discipline Funding from Tongji Hospital, Tongji University | PubMed | ||
| GJPY2337 | Sixth Cycle Key Discipline Funding from Tongji Hospital, Tongji University | PubMed | ||
| GJPY2402 | Sixth Cycle Key Discipline Funding from Tongji Hospital, Tongji University | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26297965 | Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus. | Pharmacol Ther | 2015 | https://conductscience.org/library/papers/26297965 | PubMed |
| 2 | 34782743 | Genetic-code-expanded cell-based therapy for treating diabetes in mice. | Nat Chem Biol | 2022 | https://conductscience.org/library/papers/34782743 | PubMed |
| 3 | 36658306 | Substantial Improvement of an Epimerase for the Synthesis of D-Allulose by Biosensor-Based High-Throughput Microdroplet Screening. | Angew Chem Int Ed Engl | 2023 | https://conductscience.org/library/papers/36658306 | PubMed |
| 4 | 34616030 | Engineering living therapeutics with synthetic biology. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/34616030 | PubMed |
| 5 | 27168355 | Sugar replacers: from technological challenges to consequences on health. | Curr Opin Clin Nutr Metab Care | 2016 | https://conductscience.org/library/papers/27168355 | PubMed |
| 6 | 30933864 | From synthetic biology to human therapy: engineered mammalian cells. | Curr Opin Biotechnol | 2019 | https://conductscience.org/library/papers/30933864 | PubMed |
| 7 | 25030908 | Antagonistic control of a dual-input mammalian gene switch by food additives. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/25030908 | PubMed |
| 8 | 31645456 | A green tea-triggered genetic control system for treating diabetes in mice and monkeys. | Sci Transl Med | 2019 | https://conductscience.org/library/papers/31645456 | PubMed |
| 9 | 35140213 | An optogenetic approach for regulating human parathyroid hormone secretion. | Nat Commun | 2022 | https://conductscience.org/library/papers/35140213 | PubMed |
| 10 | 31285633 | A fully human transgene switch to regulate therapeutic protein production by cooling sensation. | Nat Med | 2019 | https://conductscience.org/library/papers/31285633 | PubMed |
| 11 | 10859354 | Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10859354 | PubMed |
| 12 | 17827215 | Vitamin H-regulated transgene expression in mammalian cells. | Nucleic Acids Res | 2007 | https://conductscience.org/library/papers/17827215 | PubMed |
| 13 | 37384125 | Engineering natural molecule-triggered genetic control systems for tunable gene- and cell-based therapies. | Synth Syst Biotechnol | 2023 | https://conductscience.org/library/papers/37384125 | PubMed |
| 14 | 32995548 | Biosensor-based enzyme engineering approach applied to psicose biosynthesis. | Synth Biol (Oxf) | 2019 | https://conductscience.org/library/papers/32995548 | PubMed |
| 15 | 19549857 | Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19549857 | PubMed |
| 16 | 36906608 | Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36906608 | PubMed |
| 17 | 29858606 | Designing cell function: assembly of synthetic gene circuits for cell biology applications. | Nat Rev Mol Cell Biol | 2018 | https://conductscience.org/library/papers/29858606 | PubMed |
| 18 | 39604418 | A sensitive red/far-red photoswitch for controllable gene therapy in mouse models of metabolic diseases. | Nat Commun | 2024 | https://conductscience.org/library/papers/39604418 | PubMed |
| 19 | 34216875 | Emerging mammalian gene switches for controlling implantable cell therapies. | Curr Opin Chem Biol | 2021 | https://conductscience.org/library/papers/34216875 | PubMed |
| 20 | 30833703 | Low-calorie diets in the management of type 2 diabetes mellitus. | Nat Rev Endocrinol | 2019 | https://conductscience.org/library/papers/30833703 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41486563
GET https://conductscience.org/api/papers/v1/41486563/references?page=2